EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
96.76
+1.01 (1.05%)
At close: Apr 2, 2026

EGX:NIPH Ratios and Metrics

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
4,8381,465699405359354
Market Cap Growth
946.95%109.54%72.69%12.78%1.40%14.77%
Enterprise Value
6,0332,2821,009670317305
Last Close Price
96.7632.0116.849.087.386.76
PE Ratio
21.1211.657.753.404.005.50
PS Ratio
2.451.140.610.400.410.47
PB Ratio
4.661.971.490.850.830.95
P/TBV Ratio
4.661.971.490.850.830.95
P/FCF Ratio
-----4.72
P/OCF Ratio
-1568.742.65-73.134.46
EV/Sales Ratio
3.061.770.880.670.360.40
EV/EBITDA Ratio
11.107.416.491.362.282.84
EV/EBIT Ratio
12.278.177.034.112.533.19
EV/FCF Ratio
-8.11----4.07
Debt / Equity Ratio
1.181.331.230.440.190.12
Debt / EBITDA Ratio
2.253.213.700.430.570.40
Debt / FCF Ratio
-----0.58
Net Debt / Equity Ratio
1.151.301.150.400.06-0.18
Net Debt / EBITDA Ratio
2.203.143.480.390.19-0.61
Net Debt / FCF Ratio
-1.61-2.04-3.48-0.67-0.60-0.88
Asset Turnover
0.850.680.911.111.181.08
Inventory Turnover
2.821.822.082.262.622.09
Quick Ratio
0.600.380.350.470.570.74
Current Ratio
1.150.981.281.751.811.75
Return on Equity (ROE)
30.09%20.75%19.05%26.22%22.36%18.16%
Return on Assets (ROA)
13.26%9.20%7.14%11.25%10.53%8.54%
Return on Invested Capital (ROIC)
16.84%15.82%14.25%23.69%25.38%24.88%
Return on Capital Employed (ROCE)
31.90%25.00%17.80%30.10%28.90%25.50%
Earnings Yield
4.74%8.58%12.90%29.44%24.98%18.19%
FCF Yield
-15.38%-32.28%-22.25%-70.16%-12.21%21.21%
Dividend Yield
2.07%6.25%22.04%55.09%40.27%29.57%
Payout Ratio
29.43%39.41%71.36%34.95%37.13%70.73%
Buyback Yield / Dilution
-393.83%-196.30%----
Total Shareholder Return
-391.76%-190.05%22.04%55.09%40.27%29.57%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.